# Anna Cooreman ### Representatieve zaken - Permanent representation and advice to a **major mobile network** provider in comprehensive portfolio litigation based on several standard-essential patents, in particular with regard to antitrust law and FRAND as well as license negotiations (2015-today) - Patent representation of a **global tobacco company** and advice on e-cigarettes and coordination with numerous foreign jurisdictions (2018 – today) - Representing one of the largest companies in the field of **mobile communications** in a multi-country patent infringement case relating to standard-essential and other patents as well as border seizure proceedings at a leading global trade show (IFA) (2014-today) - Representing one of the **leading Japanese electronics corporation** in a litigation series concerning navigation devices - Representation of a **mobile phone manufacturer** in arbitration proceedings concerning a patent licensing agreement, taking into account important competition law issues as well as the determination of FRAND license fees (2012-2016) - Representation of a **nationwide automotive supplier** in patent nullity proceedings and coordination with parallel European and US proceedings (2017-2019) - Representing a **leading global automotive technology manufacturer** in a comprehensive patent infringement litigation in several countries concerning navigation systems up to the Federal Supreme Court (2011-2012) as well as concerning windscreen wipers (2014) and engine technology (2018-today) - Representation of a **Japanese multinational in the field of printing technology** (patent infringement and nullity proceedings) (2016-today) - Representing and advising a **world-renowned household goods company** regarding freedom-to-operate, patent infringement and opposition proceedings (2014-today) - Representing and advising **a global pharmaceutical company** in preliminary injunction proceedings regarding second medical use claims (2013) and supplementary protection certificates (2017-2018) - Representation of a **German medical device manufacturer** against several competitors in patent, trademark and design proceedings (2012-2016) ## Professionele lidmaatschappen - Intellectual Property Owners Association (IPO), Member of the Antitrust and European Practice Committees - European Patent Lawyers Association (EPLAW) - Licensing Executives Society (LES) - Association of Intellectual Property Experts (VPP) - German Association for the Protection of Intellectual Property (GRUR) ## Lezingen - Regular speaker at the Fordham IP Conference (NYC) on SEPs, FRAND and privateering (2012 – present) - Symposium PatentForum, Munich, 21. November 2019: “Die FRAND-Verteidigung des Beklagten außerhalb der Mobiltelefonie” - Association of Danish Intellectual Property Attorneys (ADIPA), Kopenhagen, 5. September 2019: “Right of exemption from the duty to give evidence / Client-Attorney-Privilege” - Fair Standard Alliance (FSA), Brüssel, 13. März 2019: “FRAND case law in Germany (Europe)” - Groupe Rhone-Alpes des proprieté industrielle (GRAPI), Lyon, 22. Januar 2019: - Academy of European Law (ERA), Brüssel, 25. Oktober 2018: “FRAND litigation in the European Union and the USA” - LES FRANCE, Paris, 3. Juli 2018: “FRAND in Germany” - DIS 40 Rhein-Ruhr, Düsseldorf, 31. Mai 2017: “Standard-essentiel patents und FRAND since Huawei ./. ZTE” - IPO European Practice Committee Conference, Frankfurt, 12. Mai 2016: “Admissibility of evidence in Europe obtained through U.S. litigation” - Licensing Executive Society (LES): Licensing Projects, Presentation of Module I: Introduction to the exploitation of intellectual property rights, 19.02.2016, Stuttgart - IBC Biotech & Pharmaceutical Patenting 2014, Munich: Second medical use & dosing regimens